genedrive plc (LON:GDR – Get Free Report) shares were up 14.6% on Wednesday . The stock traded as high as GBX 2.04 ($0.03) and last traded at GBX 2.04 ($0.03). Approximately 7,311,451 shares traded hands during trading, a decline of 49% from the average daily volume of 14,323,053 shares. The stock had previously closed at GBX 1.78 ($0.02).
genedrive Stock Performance
The company has a debt-to-equity ratio of 8.57, a current ratio of 1.63 and a quick ratio of 5.52. The company’s fifty day simple moving average is GBX 2.90 and its two-hundred day simple moving average is GBX 3.13. The stock has a market cap of £10.33 million, a price-to-earnings ratio of -48.25 and a beta of -0.04.
Insiders Place Their Bets
In other genedrive news, insider Ian David Gilham acquired 1,000,000 shares of the stock in a transaction on Wednesday, August 14th. The shares were purchased at an average price of GBX 3 ($0.04) per share, for a total transaction of £30,000 ($40,171.40). Corporate insiders own 14.78% of the company’s stock.
genedrive Company Profile
genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive system, a rapid thermocycler and signal detection system and semi- automated system used forqualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.
Further Reading
- Five stocks we like better than genedrive
- What is a Secondary Public Offering? What Investors Need to Know
- Rocket Lab Stock Soars: Should Investors Chase the Rally?
- Why Are These Companies Considered Blue Chips?
- KB Home Slips After Earnings: What’s Next for Homebuilders?
- What Does Downgrade Mean in Investing?
- Micron Stock Soars as AI Demand Fuels Big Q4 Earnings Beat
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.